Long COVID still affects people worldwide with stubborn symptoms like fatigue and cognitive issues. A clinical trial tested whether boosting NAD+ using nicotinamide riboside could help. Although overall group differences were limited, many participants showed encouraging improvements after taking NR for at least 10 weeks. The findings suggest NAD+ enhancement may offer symptom relief for some individuals.
